Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |